Clinical trial
MMF and Calcineurin Inhibitor Withdrawal in CAN
NCT00204230 · University Hospital Muenster, Other · Terminated
Key facts
| NCT number | NCT00204230 |
|---|---|
| Title | MMF and Calcineurin Inhibitor Withdrawal in CAN |
| Official title | Randomized Controlled Study: Effect of Mycophenolatmofetil in Patients With Histologically Proven Chronic Allograft Nephropathy |
| Lead sponsor | University Hospital Muenster, Other |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Immunosuppressive Agents, Kidney Failure, Chronic, Kidney Transplantation |
| Intervention type | Drug |
| Interventions | mycophenolate mofetil (drug) |
| Enrollment | 86 |
| Start date | Oct 1, 1999 |
| Completion | Sep 1, 2002 |
| First posted | Sep 20, 2005 |
| Last update posted | Sep 20, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: